Strategic Partnership Curida has recently formed a strategic partnership with Rommelag SE & Co, a global leader in Blow-Fill-Seal (BFS) technology, signaling expanded capabilities and potential co-development opportunities for BFS-based sterile fill systems.

European CDMO As a Norway-based contract development and manufacturing organization with a 10th anniversary and unified branding, Curida presents a regional European CDMO option for pharma companies seeking sterile and aseptic manufacturing with flexible, lean operations.

Eco Recognition Curida achieved the EcoVadis Bronze award, which can be leveraged in sales conversations to differentiate as a supplier with recognized sustainability practices appealing to customers and investors prioritizing ESG criteria.

Invested Growth Significant private equity funding from Signet Healthcare Partners and other investors in 2024 indicates strong growth traction and potential for scale-up projects, capacity expansion, and longer-term manufacturing collaborations.

Broad Customer Fit Core competencies in sterile BFS and nasal spray manufacturing enable Curida to target both small biotech and large pharma clients seeking specialized aseptic fill‑finish capabilities, offering flexible partnership models and responsiveness.